MedPath

Does vitamin D3 has any effect in preventing preeclampsia and its complication in pregnant females

Phase 4
Registration Number
CTRI/2023/08/056852
Lead Sponsor
BPS Govt. Medical College Khanpur Kalan, Sonipat
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Pregnant females who are willing to give written informed consent to participate in the study.

2. Pregnant females of age group 21-35 years with a singleton pregnancy and with a gestation age of 18-19 weeks.

Exclusion Criteria

1. Pregnant females who are unable or unwilling to give written informed consent.

2. Fetal abnormalities in the current or previous pregnancy

3. History of recurrent miscarriage

4. History of pre-eclampsia

5. History of hypertension

6. Twin pregnancy

7. Chronic kidney and liver disease

8. History of malignancy

9. Known case of osteomalacia

10. Recent history of therapeutic vitamin D3 consumption other than supplementation in the study

11. History of seizures

12. Known case of Diabetes mellitus

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pre-eclampsia assessment by blood pressure & proteinuriaTimepoint: Baseline 24 weeks, 28 weeks, 32 weeks & 36 weeks of gestation
Secondary Outcome Measures
NameTimeMethod
Serum vitamin D & calcium levels, kidney function tests, liver function tests, lipid profile and cordblood vitamin D levelsTimepoint: Baseline & 36 weeks
© Copyright 2025. All Rights Reserved by MedPath